Renaissance Capital logo

Helix Acquisition Priced, Nasdaq: HLXA

Blank check company formed by Cormorant Asset Management targeting healthcare.

Industry: SPAC

Latest Trade: $10.56 0.00 (0.0%)

First Day Return: +4.9%

Return from IPO: +5.6%

Industry: SPAC

We are a newly incorporated blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We have not selected any potential business combination target. While we may pursue a business combination target in any business or industry, we intend to focus on healthcare or healthcare related industries, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. Our sponsor is an affiliate of Cormorant Asset Management, LP (“Cormorant”), a leading life sciences focused investment firm with over $2 billion in assets under management as of June 30, 2020. Since its inception in 2013, Cormorant has focused exclusively on the healthcare industry and invests, throughout their growth cycle, in companies that discover and develop therapeutic drugs or medical technology. Cormorant primarily focuses on financing rounds taking place prior to initial public offerings known as “crossovers.” Cormorant is among the most active life-science crossover investors in terms of number of investments since 2015 with investments in over 100 privately held, life science-focused companies over this period.
more less
IPO News for Helix Acquisition
more
IPO Data
IPO File Date 10/01/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/19/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Boston, MA
Founded 2020
Employees 2